CD33 and acute myeloid leukemia: The binding epitope for GO is on the IgV domain, whereas 50% of CD33-positive AML patients express a single nucleotide polymorphism (SNP), rs12459419 C > T, that leads to a CD33 splice variant (SV) lacking the IgV domain [29].